Drug Trials Snapshots: NGENLA
Summary
NGENLA is a human growth hormone for the treatment of children 3 years of age and older who are not growing because they have growth hormone deficiency (GHD).
Description
NGENLA is a human growth hormone for the treatment of children 3 years of age and older who are not growing because they have growth hormone deficiency (GHD).
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source